Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.

Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia.

OBJECTIVE: Therapies that deplete lymphocytes often improve symptoms in patients with otherwise refractory autoimmune disease but may result in long-term lymphopenia, the consequences of which are uncertain. To assess the impact of prolonged lymphopenia on morbidity and mortality, we studied patien...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Isaacs, J, Greer, S, Sharma, S, Symmons, D, Smith, M, Johnston, J, Waldmann, H, Hale, G, Hazleman, B
Μορφή: Journal article
Γλώσσα:English
Έκδοση: 2001

Παρόμοια τεκμήρια

Παρόμοια τεκμήρια